For pharmaceutical companies aiming for US FDA approval, a regulatory dossier is crucial, serving as the scientific and legal basis for product approval. However, even well-prepared submissions may have hidden gaps or compliance issues that can lead to regulatory queries, delays, or rejections. Zenovel offers dossier due diligence services in North America to effectively aid in managing complexities.
Understanding Dossier Due Diligence
Regulatory dossier due diligence involves a detailed scientific and regulatory review of submission documents. This assessment checks for completeness, accuracy, and compliance with regulations and identifies potential risks in CTD or eCTD regulatory dossiers. It aids pharmaceutical companies in pinpointing documentation gaps and regulatory dangers before product acquisition, licensing agreements, partnerships, or regulatory submissions.
Why Due Diligence Matters
Pharmaceutical and biotechnology companies are moving from R&D to commercialization due to rising development costs and timelines. They now prefer product acquisition and licensing to cut R&D expenses and speed up market entry. The acquisition process begins with due diligence, which aims to identify regulatory risks associated with registration or commercialization, following ICH guidelines.
For companies aiming at the US market, minor deficiencies in FDA filing can lead to rejection. Conducting a thorough due diligence review can help identify these issues early, thus avoiding costly delays.
The US Regulatory Landscape: What’s at Stake
Key Submission Pathways
The US FDA has various pathways for drug approval, each with specific dossier requirements.
Each pathway requires a dossier formatted as per the Common Technical Document (CTD), including specific regional requirements for Module 1.
The Cost of Non-Compliance
The consequences of inadequate dossier preparation are severe:
What a Dossier Due Diligence Review Covers
A comprehensive regulatory dossier due diligence review covers all modules of the Common Technical Document (CTD/eCTD):
The review evaluates labeling information and risk management plans and assesses alignment with regulatory requirements of authorities such as the FDA, EMA, and CDSCO.
Zenovel offers comprehensive due diligence services for pharmaceutical products, focusing on regulatory compliance, risk mitigation, and improving the likelihood of dossier approval. With a team located in major global regions such as India, the USA, Canada, and the EU, Zenovel integrates international regulatory expertise with local market understanding.
Comprehensive Dossier Review Services
Zenovel’s dossier due diligence services include:
Zenovel provides comprehensive support for clients across different countries, specializing in navigating regulatory requirements with proven expertise. Our services enhance cost and time efficiency during the acquisition phase, expedite product market entry, and ensure compliance with strict regulatory standards, thus improving dossier approval success rates. We offer end-to-end support throughout the dossier in-licensing and due diligence processes, alongside strategic planning to facilitate effective partnerships with pharmaceutical companies.
Zenovel offers expert due diligence services to enhance your US regulatory submission, helping to accelerate the FDA approval process.
